A critical breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This vital cancer suppressor protein is frequently lost in several forms of malignancies, causing https://madesocials.com/story7519506/vhh-fragments-reactivate-p53-a-potential-hope-for-tumor-therapy